*****This thread is setup mainly to gain information
relating to Mediwatch in a quick and easy way and IS IN NO WAY A
RECOMMENDATION TO BUY!********


Mediwatch-A Synopsis:
Mediwatch was established in 1996 and has developed a range of specialist
medical equipment for the diagnosis of urological disorders.The group joined the
AIM in 2000 through a reverse into Prostcare plc,which at the time was valued at
8m.While the vast majority of sales were generated in the UK,there was a
substantial indirect export business involving a number of agents,supplying into
Europe,North America,Australasia and Asia,notably Japan.
Group revenues are set to increase rapidly following the acquisition of the former
Medtronic Urodynamis Division,which has introduced a fundamental presence in
North America.The deal was in 2006 with the sales division building from 2007.
With the inclusion of the Medtronic systems now owned by Mediwatch they now
can offer a 'One Stop Shop' for the diagnosis of various urology disorders with the
benefit of Mediwatch systems having the ability to electronically send data from the
various tests to a central data base!Oh and plus the added bonus of PSAwatch and
now PCA3plus!

More than 30 million PSA tests are performed annually in the USA alone!

CHARTS

FUTURE EVENTS AND LATEST
NEWS

Just for the record and to even things up,this is Treblewide's view (near end
of 2008):

"in short 3p by chrimbo and a real chance if they do not get rid of management they
will go into receivership.....when they bough the MDT business I said at the time it
must have been a bag of shite as they only paid buttons for it.......looks like that was
fairly correct......i feel sorry for shareholders"

Treblewide has been filtered from my eyes for his abuse,lies and general behavior but
it's a free country (I think) so do as you see fit.


It started with:

Treblewide - 05 Jun 2007 15:49 - 33 of 1747
still short

Treblewide - 18 Jun 2007 00:24 - 69 of 1747
interesting stuff from that article...very few men die from prosate cancer and it is not an agressive disease....treatment can be worse than the disease.......kind of suggests their whole business model is based on sand to me.......but hey who wants a balanced view.

Treblewide - 18 Jun 2007 00:31 - 76 of 1754
exercise and sex may cause a raised PSA...so you guys may have stumbled on a test for fit shaggers :-)

I am gonna name Me-Di-Watch

Gonna-go-bust-soon-iwatch

Treblewide - 18 Jun 2007 10:59 - 85 of 1754
minder...i do not make light of prosate cancer....show me one post where I do...i make fun out of this company yes but not the disease so wind yer neck in pal.

show me any trace of a profit and i will maybe change my mind

Treblewide - 18 Jun 2007 15:54 - 97 of 1754
minder made a small loss yes which I have more than made up for shorting it........and i guess your average holding is 3p.....aye right.

Aalso I closed out my short at 8p for a loss of the spread if memory serves me correctly.

currently short from 13.25....i thank you and goodnight

Treblewide - 23 Jul 2007 12:36 - 154 of 1747
more of the same......thank god i still do not own shares in this lot...will they ever
make a penny profit....looks doubtful......cannot even manage a small supply chain.


ect ect ect

with the last few posts:

Treblewide - 30 Mar 2009 09:16 - 1704 of 1754
you are a lunatic mick.....words fail me.

and ps i only post under treblewide on any financial web site....i know you cannot say the same......you have been calling this as a buy and nothing but a buy for about 7 years...it says it all really about your stock picking ability

i notice the downtrend ins now establishing itself....re-visit of the lows again by the looks of things

Treblewide - 30 Mar 2009 22:41 - 1712 of 1754
mick no i dont know what each product does...i dont think that is important...the numbers tell everything and even though you must spend hours on web sites searching for stuff that is not even related to MDW you fail to grasp the basics...they consistently lost money and now seem to be making some...my call to 3p was correct and i think if they had not got their shit together they could have gone under

i was not interested in them as a long play while they were loosing money depsite whatever rubbish you posted regarding piss sticks or whatever you bang on about.

and yes it was poor trading..having an avergae of 12 and averaging down to 6-7p while they were at 3p....is terrible trading...that cannot even be debated...the very fact you know so much about the products means you have fallen in love with this company......which is very dangerous when investing....

the numbers are the important things...i was right on 3p, the company is posting slightly better figures but we are in a bear market which has not bottomed yet so the price will fall further

you are a 1 trick pony that posts irrelevant links...dont bother to respond i can be bothered getting into a debate with you.....away and cut and paste some more flags

toodlepip

**************************************************************

I have been chased from here and now ADVFN,has the boy got a problem?

treblewide - 3 Aug'09 - 14:46 - 22345 of 22412


post 22342 is classic.....so mick advfn is not a good source when the consensus is sell?

begs the question why you spend so much time polluting it with your bull tripe?

question....so MDW share price has gone up, it has gone down etc etc...during all of that time has mick ever been able to find any subjectivity in his posting ie has he ever critisised anything?

i really think he may be getting paid by MDW...the whole thing is very bizzare.

mick i notice you referred to your threads as "promotion of Mediwatch"

can you confirm if you are getting financially rewarded by the company for this?

treblewide - 3 Aug'09 - 23:55 - 22371 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....



treblewide - 4 Aug'09 - 00:19 - 22373 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....

treblewide - 4 Aug'09 - 10:49 - 22379 of 22412


still time to get out at 6p.....dont understand why you would not sell at 6p when they are obviously going to half in value...if you are a long term mdw bull you can buy twice as many shares at 3p and maybe possibly one day see a profit on your holding?



treblewide - 4 Aug'09 - 12:44 - 22381 of 22412


last chance to sell at 6p for your shares folks


treblewide - 4 Aug'09 - 14:48 - 22387 of 22412


so question...is psawatch is so great...why has there been no huge surge in revenue figures from UK and Europe on the back of it being sold?

the whole reason a lot of you hold this is psawatch...it has not made them any money in Europe which could be argued when taken as a whole is not much smaller than the USA.....this company is not going to change overnight with US approval...at bets it would be a selling opportunity for long term holders

i really think a lot of you have to ignore some of the nonsense ramping going on here...the company is draining cash and there margins are reducing (despite this wonder PSA machine they have for sale)

i really think the future looks bleak for mediwatch...if someone can put in concise terminology why MDW is a buy i am all ears....dont point me at fairfax report...they are a bunch of clowns as well...that interim report is shocking and i mean really poor.

costs out of control...margins squeezed, cash running out...no real revenue growth, does this sound like a growth company to you?

sell at 6p


treblewide - 4 Aug'09 - 15:50 - 22391 of 22412


god i have heard it all now...mick can you counter my points about declining margins and cash issues without nonsense posts about peopel having insider information...what a crock and what a clown.

so just so i have this straight in my head...when you put in effort to ramp these shares it is all great and you expect cuddles? (and if anyone disagrees you throw your toys out the pram liek an old woman)

when i put up a few posts to explain why i am short it is an organised attempt to get the share price down because i have insider inforamtion from the US?

were you the Iraqi information minister in a previous role? lol


treblewide - 5 Aug'09 - 19:24 - 22409 of 22412


lol.....shares getting sold today at 5.75.....next stop 3p...

treblewide - 4 Aug'09 - 12:44 - 22381 of 22408 edit


last chance to sell at 6p for your shares folks




treblewide - 5 Aug'09 - 19:29 - 22410 of 22412


i wonder what thier overdraft is limited to....1M?

if so they have 12 months of life left at current perfomance...how many of you hlders have considered the chances of them going bust?....i would not rule it out...would love to know how much further the banks will let them go into debt before they pull the plug

treblewide - 5 Aug'09 - 19:37 - 22411 of 22412


seriously if i were a holder i would look at the interims and ask how much longer can they go on burning cash.......and with all the averaging down the bulls have done over the years i bet some are more exposed than they should be....good luck...think you might need it




ANYWAY

http://mediwatch.blogspot.com/

World-Renowned Prostate Surgeon David B. Samadi, M.D. Clarifies Prostate Screening and Treatment Options for Primary Care Physicians in Geriatrics Medical Journal

March 5 2009

Prostate Cancer Screening Options

The current methods for diagnosing prostate cancer involve using serum prostate-specific antigen (PSA) and digital rectal examination (DRE) tests. Although these methods have saved countless lives through early diagnosis since their adoption in the late 1980s, the interpretation of PSA results remains a challenge due to the natural fluctuations of PSA levels even in healthy men. In the article, Dr. Samadi predicts, "It now appears likely that PSA velocity (calculated over the course of at least 18 months) is more predictive of prostate cancer than the absolute PSA value."

http://www.marketwire.com/press-release/RoboticoncologyCom-957805.html

Prostate Cancer: The New Landscape - Abstract

Friday, 06 March 2009

This review highlights current features of the changing landscape of the US population with newly diagnosed prostate cancer and discusses new treatment options utilizing noninvasive or minimally invasive management.

Recent evidence of significant changes in the current prostate cancer landscape is based on clinical data and pathological specimens after radical prostatectomy that suggest a further increase of the low-risk patient population that may require reconsideration of treatment options. For a select cohort of patients with low-risk features, based on the D'Amico definition, active surveillance or focal ablative therapy may be a rational alternative to surgical prostatectomy or whole-gland radiation therapy that still dominate as the main treatment approaches for localized prostate cancer.

As the prostate-specific antigen era continues to mature, we continue to witness stage migration. A growing segment of the localized prostate cancer patient population has very low-volume, low-grade disease. Although active surveillance may be an appropriate approach for a selected group of patients, the progression requiring whole-gland therapy remains a challenge. Organ-sparing focal therapy might ideally fill the gap between a surveillance strategy and whole-gland treatment providing a reasonable balance between cancer control and quality of life.

Written by:
Moul JW, Mouraviev V, Sun L, Schroeck FR, Polascik TJ.

http://www.urotoday.com/61/browse_categories/prostate_cancer/prostate_cancer_the_new_landscape__abstract.html

Are prostate cancer screening trials a giant waste of time and money?

Posted on March 4, 2009 by E. Michael D. ("Mike") Scott

"It is tempting to wonder whether we have over-emphasized the idea that the value of screening is directly correlated with risk for mortality. That may well be the case when the risk of early death is the actual priority. However, when the real risk to most patients may be their quality of life over time, maybe screening is every bit as justified, but on quite different grounds."

http://prostatecancerinfolink.net/2009/03/04/are-prostate-cancer-screening-trials-a-giant-waste-of-time-and-money/

The Friday news report: March 6, 2009

Posted on March 6, 2009 by E. Michael D. ("Mike") Scott
The four reports dealt with in todays news all relate to accuracy of initial diagnosis based on available data and subsequent prognostic implications:

http://prostatecancerinfolink.net/2009/03/06/the-friday-news-report-march-6-2009/

Not sure how far into 2009 it will be before we get updates on the following but will make interesting reading when they arrive,imo:

Assisted Living Facilities

The Assisted Living Facility market is a large market that has been identified in the USA which requires urological diagnostics.
Recent legislation outlines how patients should be cared for, particularly those suffering with incontinence. We have hired a specialist to design a programme that will help us break into this lucrative market during 2009.

I think it's worth gathering up a few previous posts and combining them into one.

The NHS Purchasing and Supply Agency published their buyers guide for Urodynamic Systems in December 2008:

NHS-Buyers guide for Urodynamic Systems

From MDW's Annual Report:

Urodynamics

A comprehensive, comparative assessment of clinical Urodynamic systems was performed independently for the NHS Purchasing and Supply Agency. We are proud to report that this study found Mediwatchs Urodynamic systems superior to those from competing manufacturers (Laborie, LifeTech, MMS,Andromeda and Albyn).

Mediwatch was the only manufacturer to receive a Very Good rating with five stars for its products.

This year has seen three new systems introduced through substantial redesign and
redevelopment of existing technology acquired from Medtronic. These new systems,
the Portable Urodynamic system, Clinic Laptop and Clinic with Panel PC, have been
well received world wide and are helping to improve sales.

Our research and development program is continuing to develop new, inexpensive and state-of-the-art Urodynamic systems with innovative software. These new products will allow Mediwatch to maintain this leading position in the Urodynamics market.

MDW-Annual Report


Within the Buyers Guide MDW products were the only ones that offered the HL7 format for the exporting of data.

New NHS Pathology strategy highlights HL7 as key standard
17 October 2008

In the recently published document "Evidence, safety and quality - an information strategy for NHS Pathology" it is stated:

The NHS has adopted three key standards for IT interoperability:

SNOMED CT for the unambiguous identification of clinical concepts such as diseases, findings, and procedures.
HL7 for the exchange of messages between systems from different manufacturers.
The NHS Number for the unambiguous identification of patients.

This is an excellent clear endorsement of HL7 and associated technologies from the NHS.

New NHS Pathology strategy highlights HL7 as key standard



*HL7 - Health Level Seven the protocol for the format and the content of messages that applications must use when exchanging data with each another in medical applications.

http://www.plumtreegroup.com/Solutions-Services/indicius.html


What is HL7? (.org)

Health Level Seven is one of several American National Standards Institute (ANSI) -accredited Standards Developing Organizations (SDOs) operating in the healthcare arena. Most SDOs produce standards (sometimes called specifications or protocols) for a particular healthcare domain such as pharmacy, medical devices, imaging or insurance (claims processing) transactions. Health Level Sevens domain is clinical and administrative data.

http://www.hl7.org/


HL7 UK sets out to:

educate the UK healthcare community and healthcare information system developers about HL7 standards, and promote effective and consistent implementation of HL7 standards in the UK.
identify and analyse UK healthcare business requirements for electronic communication of healthcare information.
match UK national requirement with HL7 messages, and if necessary, identifying the need for UK specific messages, profiles and implementation guides.
report to HL7 on any specific UK needs that are not met by existing HL7 standards.
prototype and pilot with clinical and business validation.

HL7 UK


Spring 2009 HL7 UK eZine.


$20 billion to jumpstart efforts to computerise US health records27 January 2009

The US administrations plans for dramatic investments in healthcare IT is likely to have a significant impact on the uptake and use of HL7 healthcare interoperability standards.

There was a strong Democratic commitment to this before the financial crisis hit, and there is certainly expectation in many quarters that the need to get more money into the economy will add momentum and urgency to the investments in healthcare IT with standards-based interoperability.

$20 billion to jumpstart efforts to computerise US health records


HL7 UK and US healthcare reform
04 February 2009

A real, funded, US national program, and substantial collaboration on standards by national initiatives would both help to drive forwards a core, consistent set of healthcare information standards for global adoption. This would be a very good thing for healthcare in the UK, and HL7 UK members have the experience to help make such standards effective.

HL7 UK and US healthcare reform


Think that's enough on HL7 :-)



Edit-

Looks like Andrew Chin was hired to make the relevant MDW equipment HL7 compliant:

EXPERIENCE:

Mediwatch, PLC., 2007 - 2008

Programmer/Network Administrator using VB, VBA, XML

Health Level 7 Project Responsible for the research and development of the HL7 protocol to be use in Mediwatch Medical Diagnostic Software and Systems, making the products HL7 compliant for the medical service field.
Physicians Letter Project research and development of the MS Word templates, used in creating the Sensic report.
As the network administrator - user support and maintenance of the office network systems and equipments.

http://www.angelfire.com/fl5/jaskchin/CreatingWebPages/Tutorial01/case4/MyResume.html


Technical References

Dan Parker

VP of Sales

Mediwatch, plc - USA

1501 Northpoint Parkway, Suite 103

West Palm Beach, FL 33407

Office (561) 260-0982





Paula Reed, MS QSRCP

National Service & Support Manager

Mediwatch, plc - USA

1501 Northpoint Parkway, Suite 103

West Palm Beach, FL 33407

Office (561) 471-2611

http://www.angelfire.com/fl5/jaskchin/CreatingWebPages/Tutorial01/case4/TechnicalReferences.html

Back in October 2008:

Mediwatch (AIM:MDW) announces that it has renewed a Distribution Agreement with Bard Ltd ('Bard'), the UK division of US company C. R. Bard Inc. (www.crbard.com).

Under the agreement, Bard will continue to distribute the Bardscan II for a further three years. The minimum value of this agreement is 1.6 million in revenue to Mediwatch over the three year period, based on minimum order quantities of 150 units per annum. The distribution territory will include the UK, France, Holland, Luxembourg, Belgium, Italy, Denmark, Finland, Sweden, Spain, Portugal and Greece.

The Bardscan II is a portable bladder scanner designed and manufactured by
Mediwatch.

The agreement also allows for the distribution by Bard of other Mediwatch ultrasound products within the UK.

Philip Stimpson, Chief Executive of Mediwatch commented:

'Mediwatch is pleased that Bard has renewed this supply agreement. Mediwatch's ultrasound technology is now firmly established as the industry standard by leaders in the urological community.'

Bard Distribution Agreement-October 2008


If we now look at the BardUK website under the link for the original Bardscan II PDF we now see this:

http://www.barduk.com/inc/getFile.asp?fileId=180&filetype=file

BardUK website

So,BardUK are now distributing or gearing up to distribute the Portascan + along with the Multiscan PVR.

Interesting to see the BardUK PDF giving the Bioscan/PSAwatch system a mention along with the Portaflow.


"Bluetooth wireless
connectivity (with
Portaflow or Bioscan
PSAwatch reader)."

The only difference between the Bardscan II and the Portascan + apart from the colours is the Bluetooth connectivity which I think we all knew but now confirmed.


For Bard to take on board the Mediwatch brand (Ultrasound),even if it's just for the UK must be seen as a feather in the cap for MDW??

Has this got something to do with PSAwatch and the roll out within the UK?

One logical thought would be that Bard recognise that PSAwatch is going to take off in a major way within the UK and with the added value the Portascan + has,as in the connectivity with the Bioscan then sales within the UK of Bardscan II may well drop!

I can understand why Bard wanted their own portable Ultrasound scanner as in the rebranded Portascan + to distribute on a global scale.The fact that their version does not include Bluetooth must be the reason they are now selling the Portascan + otherwise as is still the case they are more or less competing against themselves!The Bardscan II is cheaper than the original MDW version but does not communicate with the rest of the MDW 'family'.

Is this just the start of Bard phasing out the Bardscan II with MDW allowing Bard to be an official distributor of part or the whole range of MDW equipment and under the brand name of Mediwatch?

I may be reading too much into it all (Ed-As usual) so lets just see what happens!

This article is a bit old but the problems still exist:

Cancer is Africas silent killer
Written by Hany Besadaand and Vadim Ermakov

September 10, 2008

"While the world is focused on controlling the spread of HIV/Aids, tuberculosis and malaria in Africa, the increasing onslaught of cancer has been largely overlooked and ignored.

According to the World Heath Organization (WHO), by 2020, African states will account for over a million new cancer cases per year out of a total of 16 million cases worldwide.

Africa remains the continent least prepared to cope with the devastating effects of this new pandemic, having only a few cancer care services available.

The puzzling question for worlds leading medical practitioners at this stage, is how cancer has managed to step outside of its traditional centre point in the West and set foot in fragile Africa.

Some answers could be found in the rising pollution that is affecting an increasing number of African cities across the continent, as well as ongoing economic development and, consequently, increased life expectancy and disposable income, which has resulted in more Africans living in urban areas and adopting Western dietary patterns.

All of this have resulted in a gradual increase in cancer cases, particularly breast cancer amongst women and prostate cancer amongst men.

African men and women are not only more likely to get prostate and breast cancer respectively at a younger age, but are also more likely to be diagnosed at a more developed stage of disease.

The WHO furthermore identified the underlying causes that had resulted in an increase in cancer cases. Principally, steadily aging populations, high smoking rates, poor nutrition, which is destabilising the immune system, the spreading of a lifestyle rich in fatty foods and lacking exercise, all exacerbated the problem.

Zimbabwes autocratic President Robert Mugabe is also believed to have developed prostate cancer, which he cannot have diagnosed nor treated in Harare.

In Zimbabwes case, the surge of cancer cases in recent years has placed an even heavier burden on the countrys deteriorating healthcare sector.

It is thought that up to 80 per cent of the pharmacists, therapists, doctors, nurses, and radiologists who were trained in the country after independence have already emigrated mainly to the United Kingdom, Australia, South Africa, Namibia, and Botswana.

Although many of the cancers found in Africa are preventable or treatable when detected early enough, the grim picture of insufficient resources and a lack of basic infrastructure mean that most Africans have no access to cancer screening, early diagnosis, treatment or palliative care."


"After all, the state of health of people living in Africa must become a global concern, because it is more cost-effective to prevent a pandemic while it is in its infancy, rather than dealing with it at the development stage."


http://www.bdafrica.com/index.php?option=com_content&task=view&id=9909&Itemid=5821

Major screening initiative starts up in Lagos, Nigeria

Posted on November 4, 2008

According to the Vanguard online, the Lagos State Government this week kicked off the second phase of a free prostate cancer awareness and screening program. This initiative is based on the premise that as many as 14 million Nigerian men may be afflicted with prostate cancer, the most common cause of cancer death in Nigerian men aged 50 and above.

During a pilot phase of the study, a total of 408 men were screened, of whom 272 were normal, while 100 were requested to repeat the test after 6 months and 36 were referred to the Lagos State University Teaching Hospital for review. Following the review, 16 men were asked to undergo prostate biopsy and 8 of them have had the biopsy carried out. Three of these 8 were determined to have cancer of the prostate. Thus, in the pilot phase, at least 3/408 men screened or 7 men in 1,000 were diagnosed with prostate cancer.

http://pcafrica.wordpress.com/2008/11/04/major-screening-initiative-starts-up-in-lagos-nigeria/

Sticking with Africa but in an abstract way relating to the UK,touched on this before but a while back:

Firstly if we take The British Prostate Centre who have five centres in the UK,all in the South!

Brighton-Nuffield Hospital
Haywards Heath-Nuffield Hospital
Gatwick-Spire Gatwick Park Hospital
East Grinstead-McIndoe Surgical Centre
North Downs-North Downs Hospital


By localised prostate cancer we mean that the tumour is confined to the prostate gland with no spread elsewhere.
Often this is diagnosed by a raised PSA blood test and subsequent biopsy.
At an early stage it may not even be detectable by a rectal examination.
There are many treatment options available with good success rates and these are detailed below.

Some localised prostate cancers are extremely slow growing and may not need treatment immediately. These can just be monitored by regular blood PSA tests. We are pleased to be able to offer a 10 minute pin-prick blood test to enable this monitoring to be undertaken in a single visit.

Localised Prostate Center-PSAwatch


So,PSAwatch is being used at two Nuffield Hospitals,at least.The Nuffield chain is owned by Netcare:

"Netcare Limited, South Africas foremost private hospital and healthcare services company, today announced its financial results for the six months to 31 March 2008.

General Healthcare Group (GHG) experienced significant growth in patient admissions from the National Health Services (NHS) in the United Kingdom (UK), says Dr Richard Friedland, Netcares CEO. The considerable success we are achieving there and locally with regards to public private partnerships (PPPs) has earned us further international contracts in Egypt and Lesotho, underscoring our ability to work well with Government Departments."

Long term UK strategy pays dividends for Netcare

From the above you can see that Netcare who owns Nuffield come under the holding company General Healthcare Group as does BMI Healthcare!

General Healthcare Group-Operating Companies


For information these are the links of Hospitals:

BMI Hospitals

Nuffield Hospitals

Netcare Hospitals

Think that all I'm trying to point out is that if PSAwatch is doing well within The British Prostate Centre,as in proving to be a cost effective and useful way of carrying out the PSA test then there is a great possibility via the General Healthcare Group to fast track (if not already being done) to South Africa!

Pheeeew

Right,now carrying on from that...............................

Part of Netcare is InHealth:

Welcome to the London NHS Diagnostic Service website. Were here to help GPs, Practice Managers and patients; so whether youre making a referral or awaiting a test or scan youll find all the information you need.

The London NHS Diagnostic Service provides fast, local access to diagnostic procedures in the Primary Care Setting across the Greater London area. This service was established to reduce patient waiting times, and help meet the 18 week referral-to-treatment waiting time targets (For information on the "18 week target" click here).


InHealth Netcare



About Us

The London NHS Diagnostic Service is an innovative service available to GPs and other healthcare professionals across the Greater London area. InHealth Netcare is delivering this service on behalf of the NHS London, and provides you with rapid access to high quality diagnostic procedures.

InHealth Netcare is an independent sector healthcare provider with a proven track record of 15 years experience and compliance with the NHS and their procedures.

InHealth-About Us



Welcome to Netcare

Netcare is a leading provider of high quality, accessible healthcare services,
with established international operations and a passion for healthcare.

Our UK operation consists of these specialist services:


Surgical centres - Greater Manchester, Stracathro, Patient Choice Programme
Cataract centres - throughout the UK
NHS Walk-In Centre - Leeds
Diagnostic centres - delivering services through the joint venture InHealth Netcare

Our services are built on five foundations:



Patient care
Clinical pathways
Clinical governance
Our people
Performance measurement



Netcare UK

So,now we see openings for the whole/part MDW range ie Diagnostic centres

I'll just lob this here to save me looking back:

Brighton-Nuffield Hospital
Haywards Heath-Nuffield Hospital
Gatwick-Spire Gatwick Park Hospital
East Grinstead-McIndoe Surgical Centre
North Downs-North Downs Hospital


North Downs Hospital
Ramsay Health Care UK
46 Tupwood Lane
Caterham
Surrey CR3 6DP

List of Ramsay Health Care Hospitals in the UK


Welcome to Ramsay Health Care, a global hospital
group operating over 100 hospitals and day surgery
facilities across Australia, the United Kingdom and
Indonesia...people caring for people

http://www.ramsayhealth.com.au/

Interesting two page article from Wales,again! I like this bit:

"I am certain screening will be offered soon, so why hide behind the rest of the UK decision-makers? Lets blaze the trail on something that will save lives and money in Wales."

http://www.walesonline.co.uk/news/health-news/2009/03/09/keith-cass-prostate-cancer-and-me-91466-23095496/

Hmmmm,lost my translator so will have to check later but not sure why Infomed are saying that PSAwatch and other MDW equipment are 'new' as they have been showing them for 6 months or more!

http://infomed.com.ru/uro_all/quicktest.html#BioScan

Some information on the current state of prostate cancer within Africa:

CANCER SCOURGE IN AFRICA IS REAL

Social hygiene standards everywhere on the African continent are either poor, very poor or non-existent. Environmental and ecological degradation have assumed an alarming rate with pollution of all types (air, water, soil) going on neither unchecked nor regulated by the appropriate authorities. Smoking and second hand smoking which every day harm the lungs of both the elderly and young are happening as if they are of little or no consequence. Processed foods, (usually processed without adequate quality control mechanism) including alcohol and beverages have replaced the type of food which the African male was used to.


The world is changing fast and as we embark on gigantic industrialization campaigns, African governments should not lose sight of the attendant health consequences. Appropriate regulatory bodies must step up awareness campaigns on the consequences of industrialization, urbanization and westernization. Multi-nationals operating in Africa should chip in their widow's might towards the health education and awareness of the African populace.


This is where the recent efforts by the Lagos State government to set up prostate cancer screening and testing centers all over the state should be commended. The federal government of Nigeria and other governments in Africa should emulate the Lagos State's example. Fortunately, prostate cancer is curable if diagnosed early. Male children from the ages of 18 should be taught in school of the signs and signals to look out for around the area of their vital organs, in this deadly battle to fight the scourge called prostate cancer. Cancer is the costly price that comes with industrialization and modernization of all genres. The African male is paying for it disproportionately.

http://nigeriaworld.com/columnist/offoaro/042908.html


750 men benefit from free prostate cancer screening in Lagos
Written by Chioma Obinna & Doyin Adekunle
Tuesday, 04 November 2008

On the premise that an estimated 14 million Nigerian men afflicted with prostate cancer, the most common cause of cancer death in Nigerian men aged 50 and above, the Lagos State Government last week kicked off the 2nd phase of the free prostate cancer awareness and screening programme.
The programme which began November 3 - 7, 2008 is targeting no fewer than 750 men aged 50 and above and will take place in Ikeja, Amuwo-Odofin and Ikorodu Local Government Areas of the State.

State Ccommissioner for Health, Dr. Jide Idris in a statement noted that the two most common tests for prostate cancer including Digital Rectal Examination (DRE) and Prostate Specific Antigen (PSA) measurement would be combined and offered free of charge during the exercise.

http://www.vanguardngr.com/index.php?option=com_content&task=view&id=20907


HEALTH

In the health sector, our central policy thrust revolves around expanding and improving our capacity to provide curative health care at the secondary and tertiary levels while also emphasizing preventive care through the provision of primary health care especially for women and children. Apart from sustaining the provision of free health care for children under five, the aged above 60 and free ante-natal care for women, we have further expanded services of free screening and treatment for a number of silent killer diseases such as Tuberculosis, Diabetes, High blood pressure Prostate cancer and Breast cancer.

Lagos State-2009 Budget


Ghana spearheads research on prostate cancer

A new technology being developed in Ghana could help Prostate cancer patients in Africa.

11 March 2008

http://africasciencenews.org/asns/index.php/News/Latest/index.php?option=com_content&task=view&id=208&Itemid=1

Interesting report:

"According to this new report, approximately a third of African American men can expect a lifetime diagnosis of prostate cancer, which is not an encouraging figure, and only adds to the pressure on researchers to find better ways to discriminate between those men who really do need treatment and those who can be managed effectively with active surveillance."

Cancer Facts & Figures For African Americans 2009-2010

Delaying bladder cancer surgery increases mortality
Mon Mar 9, 2009 2:50pm EDT

NEW YORK (Reuters Health) - In patients with stage II bladder cancer, the risk of death from cancer and other causes increases if surgery is not performed within 12 weeks of diagnosis, U.S. researchers report.

http://www.reuters.com/article/healthNews/idUSTRE5285YS20090309?feedType=RSS&feedName=healthNews

After being called a 'ramper' over on the 'dark side' I would just like to point out that I am a long term holder that probably appears to be short term by my feverish postings but that's just because I enjoy the research and at the same time want to gain as much information on my investment.

Therefore please do not buy any shares in MDW based on my postings here as they are mainly for my own use.If anyone reads this thread and it helps in either the buying or selling of shares in MDW then I'll take that as a positive too.